• credo@lemmy.worldEnglish
    2·
    5 months ago

    This article doesn’t cover it (specifically) so I went digging to see if this might compete with weight loss drugs as well:

    Victoza (liraglutide) is also used to treat obesity. While it was originally approved for the treatment of type 2 diabetes, it has also been approved under the brand name Saxenda for chronic weight management in adults with obesity or who are overweight with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia. Saxenda and Victoza contain the same active ingredient, liraglutide, but they are marketed and dosed differently depending on the indication.

    Google said:

    As of April 2024, the list price for a 30-day supply of Saxenda (liraglutide) is around $1,350, but the actual cost can range from $1,590 to $1,656 without insurance or discounts.

    • slaacaa@lemmy.worldEnglish
      2·
      5 months ago

      Lol, in Europe Saxenda costs around 100 per box. Victoza and other versions for diabetics are even cheaper, as they are subsidized by health insurance (while Saxenda is not).

      • Archelon@lemmy.worldEnglish
        5·
        5 months ago

        But how else can the poor widdwe phawmaceuticaw congwomewate affowd to lobby government and aggressively market our crap to overpaid private healthcare companies so we can keep overcharging the fuck out of drugs we can make for pennies do aww ouw impowtant weseawch that’s paid for by taxpayers with subsidies and grants.